Ankle Sprain Treatment in the ED: Pain Med Trends Examined
Overall, opioids were found to have accounted for the majority of medications used in the ED and prescribed at discharge.
Nonnarcotic Analgesics
Vazalore, a Liquid-Filled Capsule Formulation of Aspirin, Gets FDA Approval
Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications.
FDA Approves Acetaminophen Injection in Multiple Doses
The product is available in flexible PAB® intravenous (IV) Bags in 1000mg in 100mL and 500mg in 50mL doses.
Opioid-Minimizing Pain Management Feasible for Trauma Patients
MAST MMPR regimen includes oral acetaminophen, naproxen, gabapentin, lidocaine patches, and as-needed opioids
FDA Approves Posimir for Postsurgical Analgesia
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
MPR Weekly Dose Podcast Episode 64
This week we have news of the neutralizing response of the Pfizer-BioNTech vaccine to the new COVID-19 variant; A trial investigated ravulizumab in adults with severe COVID is halted; A rapid blood test for concussions gets the all clear; A novel treatment for chronic kidney disease in patients with type 2 diabetes; And the drug manufacturer Fresenius Kabi announces a voluntary recall of one lot of an NSAID treatment.
Injectable NSAID Recalled Due to Particulate Matter Found in Vials
Ketorolac tromethamine injection, a nonsteroidal anti-inflammatory drug, is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
NSAID Use Among US Adults With Cardiovascular Disease Examined
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection
The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, bupivacaine injection) for neuraxial anesthesia.
Xaracoll Implant Available for Postop Pain After Hernia Surgery
Xaracoll® (bupivacaine HCl; Innocoll Pharmaceuticals Limited) implant is now available for acute postsurgical pain relief for up to 24 hours in adults following open inguinal hernia repair. Xaracoll is a bioresorbable collagen-matrix implant designed to deliver bupivacaine HCl to the surgical site. Each implant contains 100mg of bupivacaine HCl (equivalent to 88.8mg bupivacaine) and 75mg…
